1800 202 8726
Targeted therapy safety

Imatinib When You Have — Other Health Conditions

Age alone does not stop imatinib from working. What changes is how carefully your team monitors for side effects that are more likely when other health conditions are present.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026

  • Age is not a barrier — Imatinib targets the same protein regardless of age. Older patients respond as well as younger ones.
  • Comorbidities need attention — Heart disease, liver conditions and kidney problems all affect how imatinib is managed and how closely you are watched.
  • More medicines, more interactions — Elderly patients often take several medicines. Some interact with imatinib in ways your oncologist must know about before you start.
  • Monitoring changes the risk — Most complications are caught early when the monitoring plan is built around your existing health conditions.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Imatinib is used in elderly patients and works the same way as in younger patients. What changes is the monitoring plan. Heart disease, liver conditions, kidney problems and multiple medications all affect how closely your team watches you. Tell your oncologist about every condition and medicine you have before starting.

Does heart disease affect how you take imatinib?

Imatinib can cause fluid retention. This means swelling in the legs, around the eyes, and in rarer cases around the lungs or heart. If you already have heart failure or a weakened heart, your team will watch for this from the very first dose.

Weighing yourself every day is one of the simplest monitoring steps your team may ask you to do. A sudden gain of a kilogram or two over a few days usually means fluid is building up, not that you have gained weight from eating. Report it the same day rather than waiting for your next appointment.

A pre-existing heart condition does not automatically mean you cannot take imatinib. It means your team will plan your monitoring more carefully and may ask a cardiologist to review you alongside your oncologist.

What your monitoring plan should cover when you have other health conditions

  • Blood countsRegular full blood count checks, especially in the first months of treatment when the drug is being established.
  • Liver function testsImatinib is processed by the liver. Liver function is checked before you start and at regular intervals throughout.
  • Kidney functionKidney tests help your team spot any changes that might affect how the drug is handled by your body over time.
  • Daily weightA sudden rise of more than a kilogram or two over a few days signals fluid retention and should be reported the same day.
  • Blood glucoseBlood sugar levels can change on imatinib, particularly in patients with or at risk of diabetes.
  • Full medication reviewShare every medicine, supplement and herbal remedy with your oncologist before starting — not just prescription drugs.
  • Bone markers over timeLong-term imatinib use can affect calcium and phosphate levels. Your team may monitor these as treatment continues.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What if you have liver or kidney disease?

Imatinib is broken down almost entirely by the liver. If your liver is not working normally, the drug can accumulate to higher levels than intended. Your oncologist will assess your liver function before you start and decide whether any adjustment to the usual dose is needed.

Kidney disease has a smaller effect on imatinib levels because the kidneys play a lesser role in clearing this drug. Your team will still monitor kidney function, but significant liver disease is generally the greater concern for dose management.

If you have hepatitis B, tell your oncologist before starting imatinib. In some patients with hepatitis B, the virus can reactivate during treatment, and preventive measures may be recommended. ASCO and ESMO guidance includes this as a standard pre-treatment check.

Did you know?

Before imatinib was approved in 2001, most patients with chronic myeloid leukaemia in the chronic phase progressed to more advanced disease within a few years.

NCCN and ASCO now recognise imatinib and related medicines as standard of care across all age groups, including older patients, on the basis that age alone does not reduce the drug's effectiveness.

Source: NCCN Guidelines for Chronic Myelogenous Leukaemia; ASCO Clinical Practice Guidance

Explore 75 more Blood Cancer Targeted Medicines topics

Drug Deep Dive: Ibrutinib (Imbruvica)

All Blood Cancer Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can elderly patients tolerate imatinib as well as younger patients?

In general, yes. Imatinib works through the same mechanism regardless of age, and response rates in older patients are comparable to those in younger patients according to NCCN and ASCO guidance. What differs is the side-effect profile. Older patients are more likely to experience fluid retention, fatigue and muscle cramps, partly because they are more likely to have heart, kidney or liver conditions alongside their cancer. A monitoring plan that accounts for those conditions makes a significant difference to how safely treatment can continue.

Does imatinib interact with blood pressure medicines, blood thinners or statins?

Yes, interactions are possible. Imatinib is processed by the liver enzyme CYP3A4, and many common medicines — including certain blood pressure drugs, blood thinners such as warfarin, and some statins — either speed up or slow down this enzyme. That can change how much active imatinib is present in your body at any given time. Tell your oncologist the complete list of every medicine you take, including over-the-counter preparations, vitamins and herbal supplements, before you start imatinib. This is not optional; it directly affects your safety.

Is the dose of imatinib lower for elderly patients?

Age alone does not determine the starting dose. Your oncologist will use your cancer type, your organ function and your other health conditions to make that decision. Liver function in particular influences how the drug is metabolised. If side effects emerge, a temporary dose reduction is one of the tools your team has available; this is a standard management approach recommended in NCCN guidance and does not mean the treatment has failed or that the cancer has stopped responding.

I take a medicine for my liver. Should I stop it when I start imatinib?

Do not stop any existing medicine without discussing it with your oncologist first. Some liver medicines affect the enzyme that processes imatinib, which can change drug levels in either direction. Others need to continue because stopping them would cause more harm than any interaction would. Your oncologist and, if needed, a pharmacist can review your complete medicine list and advise on what to continue, adjust or avoid. Bring the actual packets or a written list to your next appointment.

What if my kidneys are not working well?

Imatinib is primarily broken down by the liver rather than the kidneys, so moderate kidney disease generally has a smaller effect on imatinib levels than liver disease does. Your team will still check your kidney function at regular intervals. If your kidney disease is severe, your oncologist will factor that into decisions about dosing from the start. The important thing is to tell your team the extent of any kidney problem — do not assume it is already recorded from a previous appointment.

Can I take herbal or Ayurvedic medicines alongside imatinib?

Some herbal preparations affect the same liver enzyme that processes imatinib, which can raise or lower the amount of active drug in your body without your team realising it. This does not mean herbal medicine is always harmful — it means your oncologist needs to know what you are taking so they can assess any interaction. Tell your treating team about everything, including traditional preparations. They will not judge you for it; they need that information to keep you safe and to interpret any changes in your blood results accurately.

I have diabetes. Does imatinib affect my blood sugar?

Imatinib has been associated with changes in blood glucose in some patients. If you already have diabetes, your team will watch your blood sugar more closely when you start treatment. If you take insulin or other diabetes medicines, those doses may need adjusting as treatment settles in. Report any episodes of dizziness, unusual sweating, shakiness or confusion to your treating team, as these can be signs of low blood sugar and may need a prompt response rather than waiting for a scheduled visit.

What symptoms should I report immediately when I have other health conditions?

Report the same day if you notice sudden weight gain of more than a kilogram or two over a few days, new or worsening shortness of breath, swelling in the legs or around the eyes, yellowing of the skin or eyes, unusual bleeding or bruising, or severe fatigue that is clearly different from your usual level. These symptoms can arise from imatinib's effects on the heart, liver or blood, and catching them early is what allows your team to act before they become serious. If you are ever unsure, calling is always the right decision.

Call now Book free consultation